Quick Answer
ENANTA PHARMACEUTICALS INC reported Common Stock Shares Outstanding of 21.39 million shares for the year ending 2025.
- ENANTA PHARMACEUTICALS INC showed an increase of +0.9% in Common Stock Shares Outstanding from 2024 to 2025.
- This data is from ENANTA PHARMACEUTICALS INC's annual report (Form 10-K), filed with the SEC on November 19, 2025.
- XBRL data for this metric is available from 2012 to 2025 (14 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 14 years of available data (2012 to 2025), ENANTA PHARMACEUTICALS INC's Common Stock Shares Outstanding has grown by 1,785.4%.
- Historical annual values: Fiscal year 2025: 21.39 million shares | Fiscal year 2024: 21.19 million shares | Fiscal year 2023: 21.06 million shares | Fiscal year 2022: 20.79 million shares | Fiscal year 2021: 20.24 million shares | Fiscal year 2020: 20.08 million shares | Fiscal year 2019: 19.70 million shares | Fiscal year 2018: 19.40 million shares | Fiscal year 2017: 19.12 million shares | Fiscal year 2016: 19.04 million shares | Fiscal year 2015: 18.72 million shares | Fiscal year 2014: 18.59 million shares | Fiscal year 2013: 17.93 million shares | Fiscal year 2012: 1.13 million shares.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: